Completed
Miglitol Impact on Daily Plasma Glucose in Insulin-Treated Type 2 Diabetes
Study Aim
This study aims to evaluate how Miglitol, a treatment for type 2 diabetes, affects your daily plasma glucose levels when used in combination with insulin.
What is being tested
Data Collection
Who is being recruted
Diabetes Mellitus+5
+ Diabetes Mellitus, Type 2
+ Endocrine System Diseases
From 20 to 74 Years
+5 Eligibility Criteria
How is the trial designed
Treatment Study
Phase 3
Interventional
Summary
Principal SponsorSanwa Kagaku Kenkyusho Co., Ltd.
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner
This study focuses on understanding how a medication called Miglitol impacts daily blood sugar levels in individuals with type 2 diabetes who are currently using insulin. The goal is to assess if Miglitol can provide improved blood sugar control for these patients. This research is important as it aims to find new ways to manage blood sugar levels effectively, addressing a key challenge in diabetes care.
Official TitleEffects of Miglitol on Daily Plasma Glucose in type2 Diabetes Treated With Insulin
Principal SponsorSanwa Kagaku Kenkyusho Co., Ltd.
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Treatment Study
These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.From 20 to 74 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Diabetes MellitusDiabetes Mellitus, Type 2Endocrine System DiseasesHyperinsulinismInsulin ResistanceMetabolic DiseasesNutritional and Metabolic DiseasesGlucose Metabolism Disorders
Criteria
2 inclusion criteria required to participate
type2 diabetes
postprandial plasma glucose levels ≧180mg/dl
3 exclusion criteria prevent from participating
type1 diabetes
AST(GOT) or ALT(GPT) ≧100IU/l
creatinine ≧2.0mg/dl
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has no location dataSave this study to your profile to know when the location data is available.
CompletedNo study centers